Technical Comparison
Recursion Pharmaceuticals, Inc. - Class A Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between RXRX and NVDA.
Primary Asset
RXR
Recursion Pharmaceuticals, Inc. - Class A Common Stock
Market Rank #1004267Live Price$4.05
Market Capitalization$2.4B
24h Change+6.58%
Circulating Supply597M RXRX
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$217.94
Market Capitalization$5.3T
24h Change+0.90%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | RXRX Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1004267 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $4.05 | $217.94 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $2.4B | $5.3T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock bigger than NVIDIA Corporation - Common Stock?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has a market cap of $2.4B, while NVIDIA Corporation - Common Stock sits at $5.3T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Recursion Pharmaceuticals, Inc. - Class A Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 RXRX is worth 0.02 NVDA.